Dhiren Patel, PharmD, CECES, BC-ADM, Robert Busch, MD, and Muthiah Vadugananthan, MD, MPH, provide an overview of the prevalence of renal impairment in patients with diabetes.
Expert Interviews
Experts in diabetes discuss the transition to telemedicine during the COVID-19 pandemic and its impact on diabetes care.
Dhiren Patel, PharmD, CDE, BC-ADM, BCACP; Robert Busch, MD; and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, provide insight into quality-of-life improvements that have followed advances in diabetes technology and review available continuous glucose monitors.
Robert Busch, MD, and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discuss metrics to evaluate diabetes control, including time in range and coefficient of variation.
Muthiah Vaduganathan, MD, MPH, presents a case study for a patient hospitalized with heart failure whose therapy was optimized with an SGLT-2 inhibitor.
A panel of experts provide clinical pearls for primary care providers who manage patients with diabetes and cardiovascular comorbidities.
Robert Busch, MD, provides an overview of the clinical trials supporting improved cardiovascular disease outcomes in patients with and without diabetes.
A panel of experts discuss their experience with multidisciplinary collaboration of care between primary care physicians, cardiologists, endocrinologists, and pharmacists in patients with diabetes and cardiovascular disease.
Muthiah Vaduganathan, MD, MPH, provides insight into cardiology guidelines for the use of SGLT-2 [sodium-glucose cotransporter-2] inhibitors and GLP-1 [glucagon-like peptide-1] receptor agonists and discusses the uptake of these medications in patients with and without diabetes.
A panel of experts discuss the impact of continuous glucose monitoring (CGM) on individualized patient care plans for patients with type 1 and type 2 diabetes.
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discusses goals of therapy in diabetic patients with cardiovascular disease and Robert Busch, MD, provides an overview of diabetes treatment guidelines.
Dhiren Patel, PharmD, CDE, BC-ADM, BCACP; Robert Busch, MD; and Muthiah Vaduganathan, MD, MPH, provide an overview of cardiovascular comorbidities in patients with diabetes.
Robert Busch, MD, and Diana Issacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, provide insight into the use of insulin pumps in type 2 diabetes and describe currently available smart pumps.
Experts in diabetes discuss recent advances in insulin pen technology, including connected and smart pens, and their impact on diabetes care.
Dhiren Patel, PharmD, CDE, BC-ADM, BCACP; Robert Busch, MD; and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, provide an overview of the pillars of technology utilized in diabetes care: Continuous glucose monitors (CGMs), smart insulin pumps, and connected insulin pens.
Patients are more likely to pay if you give them more options.
Don’t let bad processes costs you money.
Access to HIEs makes it much easier to respond to patients’ requests for their health data.
Health organizations can better control non-physicians even if money isn’t an issue.
All types of providers are needed for a health care team, but should these teams be led by doctors?
How HIEs can lower costs and improve quality of care.
Using information from an HIE has many benefits.
Patients often don’t understand the different levels of training required by practitioners, so organizations often push non-physicians into more roles.
Increasing demands on physician time and not being able to treat all patients takes a toll.
The information blocking rule implemented in April 2021 requires all health care organizations to share patient information.
Early retirements and a declining population of practitioners make staffing difficult.
A bad problem got even worse as the pandemic swept through the country.
What metrics should you use to track whether your practice's marketing plan is working?
Advertisement
Advertisement
